The primary objective of the VBX 17-04 registry is to collect post-market safety and performance data of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) in peripheral vessels in patients who require interventional treatment
Study Type
OBSERVATIONAL
Enrollment
280
GORE VIABAHN VBX Balloon Expandable Endoprosthesis will be implanted in peripheral vessels in patients who require interventional treatment.
Hôpital Marie Lannelongue
Paris, France
University Hospital Heidelberg
Heidelberg, Germany
St. Franziskus Hospital
Münster, Germany
Azienda Ospedaliera Policlinico Sant'Orsola Malpighi
Composite of Procedural Success and Freedom From VBX Stent Graft-related Serious Adverse Events
Number of study subjects experiencing Procedural Success and free from VBX Stent Graft-related Serious Adverse Events within 30 days of index procedure. Procedural Success is defined as: successful access, delivery, accurate deployment, and withdrawal of catheters with patent VBX Stent Graft at end of procedure.
Time frame: 30 days post treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bologna, Italy
Fondazione Poliambulanza
Brescia, Italy
Azienda Ospedaliero-Universitaria di Padova
Padua, Italy
Ospedale di Circolo e Fondazione Macchi
Varese, Italy
University Medical Center Groningen
Groningen, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Spain
...and 1 more locations